Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis: an open-label, 18-month, prospective, pilot study

ANNALS OF THE RHEUMATIC DISEASES(2019)

引用 13|浏览29
暂无评分
关键词
dmards (biologic),giant cell arteritis,systemic vasculitis,treatment
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要